ArticleJournal of ovarian research2025
The efficacy of ionomycin - induced artificial oocyte activation in preventing fertilization failure in an ICSI cycle: an eight - year retrospective study.
Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundArtificial oocyte activation (AOA) procedure may prevent the occurrence of fertilization failure following ICSI; however, the specific efficacy of AOA remains controversial. The study investigate the efficacy of AOA to prevent fertilization failure following ICSI and determine how different reasons for using AOA affect the results of AOA.
methodsThis was a retrospective cohort study that enrolled 240 patients with previous fertilization failure following ICSI (ICSI-failure), severe teratozoospermia or using immotile post - thaw testicular sperm (sperm - immotile). Using sibling oocytes, half were subjected to AOA and half to conventional ICSI (c - ICSI). Based on fertilization outcomes, AOA cycles were classified into three types: AOA - effective, AOA - invalid, and AOA - unnecessary. Multinomial logistic regression was used to analyze the associations between AOA fertilization outcomes (AOA-invalid, AOA-effect, AOA-unnecessary) and indications for AOA use (previous ICSI-failure, severe teratozoospermia, sperm-immotile). For AOA-effect group, binary logistic regression was applied to assess the cumulative live birth rate (c-LBR).
resultsThe AOA group had more normal fertilization cycles (197) than the c - ICSI group (68) (P<0.001). When comparing AOA-effect and AOA-invalid, Multinomial logistic regression revealed that ICSI-failure were more likely to result in an AOA-invalid outcome (p = 0.019). When comparing AOA-effect and AOA-unnecessary, severe teratozoospermia (p < 0.001) or sperm-immotile (p < 0.001) were more likely to result in an AOA-effect outcome. In the AOA-effect group, logistic regression showed ICSI-failure was positively related to c-LBR) (p = 0.039).
conclusionRegarding fertilization, AOA may effectively treat patients with previous ICSI-failure, severe teratozoospermia, and sperm-immotile. However, considering the c-LBR, the efficacy of AOA is limited in the latter two groups. Therefore, patient information and consent are required for using AOA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.